Download FREE Report Sample
Download Free sampleLeukocyte Surface Antigen CD47 Market contains market size and forecasts of Leukocyte Surface Antigen CD47 in global, including the following market information:
Global Leukocyte Surface Antigen CD47 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Leukocyte Surface Antigen CD47 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Leukocyte Surface Antigen CD47 companies in 2021 (%)
The global Leukocyte Surface Antigen CD47 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
B-6H12 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leukocyte Surface Antigen CD47 include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc and Trillium Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Leukocyte Surface Antigen CD47 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leukocyte Surface Antigen CD47 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, by Type, 2021 (%)
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Global Leukocyte Surface Antigen CD47 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, by Application, 2021 (%)
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Global Leukocyte Surface Antigen CD47 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leukocyte Surface Antigen CD47 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Leukocyte Surface Antigen CD47 revenues share in global market, 2021 (%)
Key companies Leukocyte Surface Antigen CD47 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Leukocyte Surface Antigen CD47 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
